Perceptive Advisors - FUSION PHARMACEUTICALS INC ownership

FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 38 filers reported holding FUSION PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of FUSION PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,153,627
-44.3%
2,751,3950.0%0.24%
-35.8%
Q2 2023$12,849,014
+23.5%
2,751,395
-0.3%
0.37%
+21.2%
Q1 2023$10,404,959
+297.0%
2,759,936
+162.2%
0.31%
+274.4%
Q2 2022$2,621,000
-72.5%
1,052,445
-14.2%
0.08%
-57.1%
Q1 2022$9,534,000
-6.8%
1,227,017
-50.0%
0.19%
+141.8%
Q4 2021$10,234,000
+3.0%
2,454,034
+95.6%
0.08%
-45.1%
Q3 2021$9,936,000
-65.4%
1,254,607
-64.7%
0.14%
-22.6%
Q2 2021$28,686,000
+37.2%
3,550,334
+82.1%
0.19%
-29.5%
Q1 2021$20,905,000
-20.4%
1,950,167
-12.8%
0.26%
-6.4%
Q4 2020$26,273,000
-2.2%
2,235,9830.0%0.28%
-28.1%
Q3 2020$26,877,000
-25.2%
2,235,9830.0%0.39%
-32.8%
Q2 2020$35,955,0002,235,9830.58%
Other shareholders
FUSION PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,670,516$9,543,3423.52%
ADAMS STREET PARTNERS LLC 2,947,809$7,664,3032.68%
Pivotal bioVenture Partners Investment Advisor LLC 1,560,982$4,058,5531.62%
SPHERA FUNDS MANAGEMENT LTD. 1,354,258$3,521,0710.64%
Avidity Partners Management LP 5,781,850$15,032,8100.60%
Eagle Health Investments LP 579,769$1,507,3990.33%
Perceptive Advisors 2,751,395$7,153,6270.24%
Ghost Tree Capital, LLC 243,287$632,5460.21%
Sio Capital Management, LLC 246,036$639,6940.20%
Artal Group S.A. 1,725,000$4,4850.19%
View complete list of FUSION PHARMACEUTICALS INC shareholders